State Street® Health Care Select Sector SPDR® ETF XLV

Morningstar Medalist Rating

Morningstar’s Analysis XLV

Will XLV outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street®HlthCrSelSectSPDR®ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XLV

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings60.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

16.859B
Healthcare

Johnson & Johnson

10.055B
Healthcare

AbbVie Inc

7.614B
Healthcare

UnitedHealth Group Inc

5.343B
Healthcare

Merck & Co Inc

5.323B
Healthcare

Thermo Fisher Scientific Inc

3.782B
Healthcare

Amgen Inc

3.672B
Healthcare

Gilead Sciences Inc

3.042B
Healthcare

Abbott Laboratories

2.741B
Healthcare

Pfizer Inc

2.401B
Healthcare

Sponsor Center